Adult HGBCL, NOS, cases had lower expression of IRF3, KRAS, and NF‐κB‐related signatures, and lower expression of stromal, myeloid, macrophage, and monocyte signatures when compared with de novo ABC‐DLBCL (Figure 5B). This evidence concerns the gene KRAS and diffuse large B-cell lymphoma.